We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $72.6B
1-Year Est. Return 54.88%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+1.23%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.93%
AUM
$77.4B
AUM Growth
-$2.68B
Cap. Flow
-$1.24B
Cap. Flow %
-1.6%
Top 10 Hldgs %
12.38%
Holding
4,070
New
663
Increased
931
Reduced
1,797
Closed
653

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$649M
2
NKE icon
Nike
NKE
+$453M
3
TSLA icon
Tesla
TSLA
+$431M
4
AZN icon
AstraZeneca
AZN
+$389M
5
KO icon
Coca-Cola
KO
+$336M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$897M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$578M
3
MRNA icon
Moderna
MRNA
+$438M
4
AAPL icon
Apple
AAPL
+$417M
5
AON icon
Aon
AON
+$386M

Sector Composition

Rank Sector Weight
1 Technology 20.4%
2 Healthcare 20.27%
3 Consumer Staples 11.15%
4 Consumer Discretionary 9.81%
5 Industrials 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INVZ icon
3251
Innoviz Technologies
INVZ
$114M
$161K ﹤0.01%
+28,000
New +$221K
LABP
3252
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$159K ﹤0.01%
+1,090
New +$141K
MNDO icon
3253
Mind CTI
MNDO
$20.6M
$156K ﹤0.01%
49,642
-7,033
-12% -$23.1K
CANF
3254
Can-Fite BioPharma American Depositary Shares
CANF
$7.28M
$155K ﹤0.01%
+467
New +$184K
SIFY
3255
Sify Technologies
SIFY
$1.15B
$155K ﹤0.01%
7,633
-21,196
-74% -$439K
SPCB icon
3256
SuperCom
SPCB
$70.3M
$155K ﹤0.01%
777
-448
-37% -$105K
PETZ icon
3257
TDH Holdings
PETZ
$15.5M
$154K ﹤0.01%
6,029
+845
+16% +$38.9K
MIST icon
3258
Milestone Pharmaceuticals
MIST
$133M
$151K ﹤0.01%
26,400
-81,154
-75% -$458K
TTSH
3259
DELISTED
Tile Shop Holdings
TTSH
$150K ﹤0.01%
19,600
+1,100
+6% +$8.42K
AXLA
3260
DELISTED
Axcella Health Inc. Common Stock
AXLA
$150K ﹤0.01%
2,011
-4,317
-68% -$370K
AGTC
3261
DELISTED
Applied Genetic Technologies Corporation
AGTC
$150K ﹤0.01%
49,840
-106,400
-68% -$379K
IMUX icon
3262
Immunic
IMUX
$226M
$148K ﹤0.01%
+1,670
New +$164K
BRCN
3263
DELISTED
Burcon NutraScience Corporation
BRCN
$148K ﹤0.01%
94,590
+57,423
+154% +$134K
CVU icon
3264
CPI Aerostructures
CVU
$75M
$147K ﹤0.01%
53,500
-95,900
-64% -$305K
CRESY
3265
Cresud
CRESY
$752M
$146K ﹤0.01%
+31,225
New +$175K
SNES icon
3266
SenesTech
SNES
$6.78M
$145K ﹤0.01%
40
-43
-52% -$166K
AAME icon
3267
Atlantic American Corp
AAME
$29M
$144K ﹤0.01%
34,700
-1,300
-4% -$5.25K
CYTO
3268
DELISTED
Altamira Therapeutics Ltd
CYTO
$143K ﹤0.01%
+178
New +$201K
CTK
3269
DELISTED
CooTek (Cayman) Inc. American Depositary Shares, each representing 650 Class A Ordinary Shares
CTK
$141K ﹤0.01%
8,892
+115
+1% +$2.32K
ASM
3270
Avino Silver & Gold Mines
ASM
$1.21B
$140K ﹤0.01%
+169,900
New +$168K
CNET icon
3271
ZW Data Action Technologies
CNET
$4.73M
$140K ﹤0.01%
5,550
-20,278
-79% -$614K
EVGO icon
3272
EVgo
EVGO
$519M
$140K ﹤0.01%
+17,118
New +$173K
IMTX icon
3273
Immatics
IMTX
$1.31B
$140K ﹤0.01%
10,733
-59,076
-85% -$751K
MG icon
3274
Mistras Group
MG
$584M
$139K ﹤0.01%
13,700
-3,400
-20% -$33.6K
ALAR
3275
Alarum Technologies
ALAR
$13.4M
$138K ﹤0.01%
12,700
-14,079
-53% -$170K
129 130
131
132 133

Similar funds

Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Jim Simons's Q3 2021 Portfolio in Review

As of Q3 2021, Jim Simons held 4,070 positions worth $77.4B, down 3.3% from $80.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Jim Simons's Q3 2021 filing shows 663 new, 931 increased, 1,797 reduced and 653 closed positions. Its largest new stake was Adobe: 1,030,433 shares worth $593M. The largest sale was Amazon, an estimated $897M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Jim Simons's largest Q3 2021 buy was Adobe: 1,030,433 shares worth $593M.
  • Jim Simons added most to Nike in Q3 2021, an estimated $453M increase.
  • Jim Simons's biggest Q3 2021 reduction was Moderna, cutting an estimated $438M.
  • Jim Simons fully exited Amazon in Q3 2021, selling an estimated $897M.
  • Jim Simons's ten largest holdings make up 12% of its $77.4B portfolio in Q3 2021.
  • Jim Simons opened 663 new positions and closed 653 in Q3 2021.
  • Jim Simons's portfolio value fell 3.3% quarter-over-quarter to $77.4B.

Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.